E
Sell
10/3/2023Downgrade
Medigus Ltd. (MDGS) was downgraded to E+ from D on 10/3/2023 due to a major decline in the efficiency index, solvency index and growth index.
D
Sell
6/16/2023Upgraded
MediGus Ltd. (MDGS) was upgraded to D from E+ on 6/16/2023 due to a major increase in the efficiency index and total return index.
E
Sell
3/14/2023Downgrade
Xylo Technologies Ltd (XYLO) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
Xylo Technologies Ltd (XYLO) was upgraded to D- from E+ on 02/23/2023.
E
Sell
2/8/2023Downgrade
MediGus Ltd. (MDGS) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index and total return index.
D
Sell
9/30/2022Downgrade
MediGus Ltd. (MDGS) was downgraded to D- from D on 9/30/2022 due to a significant decline in the valuation index, efficiency index and growth index.
D
Sell
4/29/2022Downgrade
MediGus Ltd. (MDGS) was downgraded to D from D+ on 4/29/2022 due to a significant decline in the efficiency index, total return index and volatility index.
D
Sell
9/28/2021Upgraded
MediGus Ltd. (MDGS) was upgraded to D+ from D on 9/28/2021 due to a significant increase in the valuation index, efficiency index and total return index.
D
Sell
5/4/2020Upgraded
MediGus Ltd. (MDGS) was upgraded to D from D- on 5/4/2020 due to an increase in the volatility index.
D
Sell
5/1/2020Upgraded
MediGus Ltd. (MDGS) was upgraded to D- from E+ on 5/1/2020 due to an increase in the volatility index, solvency index and total return index.
E
Sell
9/6/2018Downgrade
MediGus Ltd. (MDGS) was downgraded to E+ from D- on 9/6/2018 due to a decline in the efficiency index, solvency index and total return index. Total capital declined 24.84% from $4.47M to $3.36M, the quick ratio declined from 7.03 to 5.59, and net income declined 6.39% from -$1.08M to -$1.15M.
